The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study
Open accessAbstract
BACKGROUND: Leakage of bacterial products across the gut barrier may play a role in liver diseases which often precede the development of liver cancer. However, human studies, particularly from prospective settings, are lacking. METHODS: We used a case-control study design nested within a large prospective cohort to assess the association between circulating levels of anti-lipopolysaccharide (LPS) and anti-flagellin immunoglobulin A (IgA) and G (IgG) (reflecting long-term exposures to LPS and flagellin, respectively) and risk of hepatocellular carcinoma. A total of 139 men and women diagnosed with hepatocellular carcinoma between 1992 and 2010 were matched to 139 control subjects. Multivariable rate ratios (RRs), including adjustment for potential confounders, hepatitis B/C positivity, and degree of liver dysfunction, were calculated with conditional logistic regression. RESULTS: = 0.021). This finding did not vary substantially by time from enrollment to diagnosis, and did not change after adjustment for chronic infection with hepatitis B and C viruses. CONCLUSIONS: These novel findings, based on exposures up to several years prior to diagnosis, support a role for gut-derived bacterial products in hepatocellular carcinoma development. Further study into the role of gut barrier failure and exposure to bacterial products in liver diseases is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“one study has linked high baseline LBP and anti-flagellin IgA levels to increased risk of hepatocellular carcinoma in patients with liver disease,143”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [143]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“However, a possibility that exposure to LPS may trigger the onset of obesity and insulin resistance was also suggested in animal models [59].”
Cani, P. D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A. M., Delzenne, N. M., & Burcelin, R. (2008) · Diabetes · doi:10.2337/db07-1403 · Cited by 4,819 · cited 1×
“High exposure of the liver to these microbial products could be due to their translocation through the disrupted gut barrier, which could be a result of intestinal inflammation, chronic alcohol abuse, early phase hepatic injury, or dietary and/or lifestyle factors [24, 37, 38].”
Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity
Markle, J. G. M., Frank, D. N., Mortin-Toth, S., Robertson, C. E., Feazel, L. M., Rolle-Kampczyk, U., von Bergen, M., McCoy, K. D., Macpherson, A. J., & Danska, J. S. (2013) · Science · doi:10.1126/science.1233521 · Cited by 2,025 · cited 1×
“Nevertheless, the sex differences observed in our study might be biologically plausible, as men generally have lower innate and adaptive immune responses [47, 48], or because the gut microbiome may alter sex hormone levels and subsequently affect inflammation and autoantibody production, as has been observed in mice […”
Riboli, E., Hunt, K., Slimani, N., Ferrari, P., Norat, T., Fahey, M., Charrondière, U., Hémon, B., Casagrande, C., Vignat, J., et al. (2002) · Public Health Nutrition · doi:10.1079/phn2002394 · Cited by 1,866 · cited 1×
“The rationale and study design are described in detail elsewhere [25].”
Self-citationPromotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dapito, D. H., Mencin, A., Gwak, G.-Y., Pradere, J.-P., Jang, M.-K., Mederacke, I., Caviglia, J. M., Khiabanian, H., Adeyemi, A., Bataller, R., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.007 · Cited by 1,346 · cited 1×
“These findings provide the first prospective epidemiologic evidence on the topic and add to the existing experimental data showing that weakened gut barrier function and subsequent exposure to bacterial products may promote hepatocarcinogenesis [13, 35].”
Gewirtz, A. T., Navas, T. A., Lyons, S., Godowski, P. J., & Madara, J. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.4.1882 · Cited by 1,346
Self-citationGlobal burden of aflatoxin-induced hepatocellular carcinoma: A risk assessment
Liu, Y., & Wu, F. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.0901388 · Cited by 1,224 · cited 4×
“, NAFLD or NASH) or on exposure to aflatoxins, which is uncommon in Western Europe [54].”
InfluentialYang, S. Q., Lin, H. Z., Lane, M. D., Clemens, M., & Diehl, A. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2557 · Cited by 810
Rivera, C. A., Adegboyega, P., van Rooijen, N., Tagalicud, A., Allman, M., & Wallace, M. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.04.019 · Cited by 693
Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
Needham, B. D., & Trent, M. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3047 · Cited by 565 · cited 1×
“LPS exposure activates the innate immune system by activating the toll-like receptor 4 (TLR4)-MD2 complex, which in turn through the myeloid differentiation primary response protein 88 (MYD88)dependent and TIR domain-containing adaptor-inducing IFNβ (TRIF) (or MYD88-independent) pathways, induces the production of pro…”
Cited by
The gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737
Alcohol and Cancer: Epidemiology and Biological Mechanisms
Rumgay, H., Murphy, N., Ferrari, P., & Soerjomataram, I. (2021) · Nutrients · doi:10.3390/nu13093173 · Cited by 394
“Once in the blood these bacterial products easily reach the liver where a variety of cells are activated (endothelial cells, liver macrophages, stellate cells and hepatocytes) producing a chronic inflammatory environment [33], which may confer an increased risk of liver cancer [46].”
BackgroundChassaing, B., Compher, C., Bonhomme, B., Liu, Q., Tian, Y., Walters, W., Nessel, L., Delaroque, C., Hao, F., Gershuni, V., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.11.006 · Cited by 347
Self-citationThe Changing Epidemiology of Primary Liver Cancer
Petrick, J. L., & McGlynn, K. A. (2019) · Current Epidemiology Reports · doi:10.1007/s40471-019-00188-3 · Cited by 170
Tran, H. Q., Ley, R. E., Gewirtz, A. T., & Chassaing, B. (2019) · Nature Communications · doi:10.1038/s41467-019-13538-y · Cited by 136
Self-citation
Metadata
- Authors
- Fedirko, V., Tran, H. Q., Gewirtz, A. T., Stepien, M., Trichopoulou, A., Aleksandrova, K., Olsen, A., Tjønneland, A., Overvad, K., Carbonnel, F., Boutron-Ruault, M.-C., Severi, G., Kühn, T., Kaaks, R., Boeing, H., Bamia, C., Lagiou, P., Grioni, S., Panico, S., Palli, D., Tumino, R., Naccarati, A., Peeters, P. H., Bueno-de-Mesquita, H. B., Weiderpass, E., Castaño, J. M. H., Barricarte, A., Sánchez, M.-J., Dorronsoro, M., Quirós, J. R., Agudo, A., Sjöberg, K., Ohlsson, B., Hemmingsson, O., Werner, M., Bradbury, K. E., Khaw, K.-T., Wareham, N., Tsilidis, K. K., Aune, D., Scalbert, A., Romieu, I., Riboli, E., & Jenab, M.
- Affiliations
- Emory University (US)
- Georgia State University (US)
- National and Kapodistrian University of Athens (GR)
- German Institute of Human Nutrition (DE)
- Danish Cancer Society (DK)
- Aarhus University (DK)
- Université Paris-Sud (FR)
- German Cancer Research Center (DE)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Federico II University Hospital (IT)
- Istituto per lo Studio e la Prevenzione Oncologica (IT)
- Azienda Usl 8 Arezzo (IT)
- Italian institute for Genomic Medicine (IT)
- University Medical Center Utrecht (NL)
- Karolinska Institutet (SE)
- Instituto de Salud Pública de Navarra (ES)
- Universidad de Granada (ES)
- Basque Government (ES)
- Gobierno del Principado de Asturias (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Lund University (SE)
- University Hospital of Umeå (SE)
- University of Oxford (GB)
- University of Cambridge (GB)
- University of Ioannina (GR)
- Imperial College London (GB)
- Centre international de recherche sur le cancer (FR)
- Corresponding author
- Fedirko, Veronika
- Jenab, Mazda
- ORCID
- Fedirko, Veronika
- Tran, Hao Quang
- Gewirtz, Andrew T.
- Trichopoulou, Antonia
- Aleksandrova, Krasimira
- Olsen, Anja
- Tjønneland, Anne
- Overvad, Kim
- Carbonnel, Franck
- Severi, Gianluca
- Kaaks, Rudolf
- Boeing, Heiner
- Grioni, Sara
- Panico, Salvatore
- Palli, Domenico
- Tumino, Rosario
- Naccarati, Alessio
- Peeters, Petra H.
- Weiderpass, Elisabete
- Barricarte, Aurelio
- Sánchez, María-José
- Agudo, Antonio
- Sjöberg, Klas
- Ohlsson, Bodil
- Hemmingsson, Oskar
- Bradbury, Kathryn E.
- Khaw, Kay-Tee
- Tsilidis, Konstantinos K.
- Aune, Dagfinn
- Scalbert, Augustin
- Romieu, Isabelle
- Jenab, Mazda
- Venue
- BMC Medicine
- Published
- 2017-04-04
- Volume
- 15
- Issue
- 1
- Pages
- 72-72
- ISSN
- 1741-7015 (ISSN-L)
- PMC
- PMC5379669
- OpenAlex
- W2602650977
- Cited by
- 50
- References
- 59
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 8 · 2022: 6 · 2021: 8 · 2020: 5 · 2019: 8 · 2018: 4 · 2017: 1
- FWCI
- 3.04
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- BMC Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Research Portal (Queen's University Belfast) (submittedVersion, cc-by)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DiVA at Umeå University (Umeå University) (submittedVersion, other-oa)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by-nc-nd)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Florence Research (University of Florence) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- Rivm Repository (Netherlands National Institute for Public Health and the Environment) (submittedVersion)
- Rivm (National Institute for Public Health and the Environment) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Apollo (cc-by)
- Funders
- L’Institut National du Cancer (2009-139)
- Topics
- Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Keywords
- hepatocellular carcinoma, lipopolysaccharide, flagellin, bacterial products, anti-lipopolysaccharide antibodies, anti-flagellin antibodies, immunoglobulin A, IgG, liver cancer risk, hepatitis B, hepatitis C, liver dysfunction
- MeSH terms
- Adult, Aged, Female, Flagellin, Carcinoma, Hepatocellular, Humans, Immunoglobulin A, Immunoglobulin G, Lipopolysaccharides, Liver Neoplasms, Male, Middle Aged, Prospective Studies, Risk Factors, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study. https://app.cochat.ai/papers/10.1186/s12916-017-0830-8
- The paper
- Fedirko, V., Tran, H. Q., Gewirtz, A. T., Stepien, M., Trichopoulou, A., Aleksandrova, K., Olsen, A., Tjønneland, A., Overvad, K., Carbonnel, F., Boutron-Ruault, M.-C., Severi, G., Kühn, T., Kaaks, R., Boeing, H., Bamia, C., Lagiou, P., Grioni, S., Panico, S., . . . Jenab, M. (2017). Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study. BMC Medicine. https://doi.org/10.1186/s12916-017-0830-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
